Mobile application of Gynecological Cancer Support program

Published: 23 August 2023| Version 1 | DOI: 10.17632/cmn7zfbwby.1
Contributor:
Jiemin zhu

Description

The trial aimed to examine the efficacy of MGCS on uncertainty in illness, QoL, symptom distress, and social support in women with gynecological cancers receiving chemotherapy in China compared to routine care. We hypothesised that compared with women who received only routine care, women who received the MGCS program plus routine care would report significantly better health outcomes for uncertainty in illness, QoL, symptom distress, and social support at 12 weeks (T1) and 24 weeks (T2).

Files

Institutions

Xiamen University

Categories

Cancer Care

Licence